Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
European Journal of Human Genetics : EJHG
|
June 23, 2011
Copy number variants and infantile spasms: evidence for abnormalities in ventral forebrain development and pathways of synaptic function
Alex R Paciorkowski, Liu Lin Thio, Jill A Rosenfeld, et al.
Plos One
|
December 16, 2014
An integrative computational approach for prioritization of genomic variants
Inna Dubchak, Sandhya Balasubramanian, Sheng Wang, et al.
Nature Communications
|
April 18, 2023
Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia
Othman Al-Sawaf, Can Zhang, Hyun Yong Jin, et al.
Nature Communications
|
October 23, 2023
Author Correction: Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia
Othman Al-Sawaf, Can Zhang, Hyun Yong Jin, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
European Journal of Human Genetics : EJHG
|
June 23, 2011
Copy number variants and infantile spasms: evidence for abnormalities in ventral forebrain development and pathways of synaptic function
Alex R Paciorkowski, Liu Lin Thio, Jill A Rosenfeld, et al.
Plos One
|
December 16, 2014
An integrative computational approach for prioritization of genomic variants
Inna Dubchak, Sandhya Balasubramanian, Sheng Wang, et al.
Nature Communications
|
April 18, 2023
Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia
Othman Al-Sawaf, Can Zhang, Hyun Yong Jin, et al.
Nature Communications
|
October 23, 2023
Author Correction: Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia
Othman Al-Sawaf, Can Zhang, Hyun Yong Jin, et al.
Page
of 2